Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Panciu, Traian Constantin; Masgras, Bianca; Ciuca, Catrinel; Ciomag, Raluca; Mihăilescu, Anca; Gurghean, Adriana

Accès libre

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Panciu, Traian Constantin

,

,

,

,

et

20 juil. 2018

Édition 15 (2018): Edition 3 (Juillet 2018)

À propos de cet article

Article précédent

Article suivant

Citez

Partagez

Télécharger la couverture

Publié en ligne: 20 juil. 2018

Pages: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Mots clés
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Panciu, Traian Constantin

Clinical Hospital Colţea Bucharest

Masgras, Bianca

Clinical Hospital Colţea Bucharest

Ciuca, Catrinel

Clinical Hospital Colţea Bucharest

Ciomag, Raluca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Mihăilescu, Anca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Gurghean, Adriana

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Langue:: Anglais

Périodicité:: 4 fois par an
Sujets de la revue:: Médecine, Médecine clinique, Médecine interne, Médecine interne, autres, Cardiologie, Gastro-entérologie, Pneumologie

RSS Feed de la revue

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Bianca Masgras

Catrinel Ciuca

Raluca Ciomag

Anca Mihăilescu

Adriana Gurghean

Publié en ligne: 20 juil. 2018

Pages: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Mots clésErlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome